Transaction DateRecipientSharesTypePriceValue
1st July 2020Peter Jerome35,461Grant/award etc.$0.37$13,120.57
1st July 2020Chaim Davis35,461Grant/award etc.$0.37$13,120.57
1st July 2020Jean Neff35,461Grant/award etc.$0.37$13,120.57
8th April 2020Chaim Davis7,751Grant/award etc.$0.21$1,627.71
8th April 2020Peter Jerome7,751Grant/award etc.$0.21$1,627.71
8th April 2020Jean Neff7,751Grant/award etc.$0.21$1,627.71
2nd March 2020Chaim Davis528,571Open or private purchase$0.07$36,999.97
10th October 2019Chaim Davis37,398Grant/award etc.$0.09$3,365.82
10th October 2019Jean Neff23,014Grant/award etc.$0.09$2,071.26
10th October 2019Peter Jerome37,398Grant/award etc.$0.09$3,365.82
American Bio Medica Corporation
American Bio Medica Corporation logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 1/10.

American Bio Medica Corp. engages in the manufacture and sale of immunoassay tests. It offers products relating to urinalysis, oral fluids, alcohol testing, hair testing, pregnancy testing, contract manufacturing, and lab partners. The company was founded by Stan Cipkowski and Edmund M. Jaskiewicz in 1986.

Ticker: ABMC
Sector: Healthcare
Industry: Diagnostics & Research
SEC Central Index Key (CIK): 896747
Auditor Opinion:

Disclosure Language changes
Red Flags